Independent Data Monitoring Committee

• Bio News

  Gilead’s Twice-Yearly Lenacapavir Demonstrated 100% Efficacy and Superiority to Daily Truvada® for HIV Prevention

  Congratulations to Gilead Sciences and HIV patients!

  2024年6月21日

  135